These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31718300)

  • 21. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
    Hamdy ME; El-Gibaly SM; Montasser AM
    Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.
    Gu P; Wusiman A; Wang S; Zhang Y; Liu Z; Hu Y; Liu J; Wang D
    Carbohydr Polym; 2019 Nov; 223():115128. PubMed ID: 31427012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
    Commander NJ; Spencer SA; Wren BW; MacMillan AP
    Vaccine; 2007 Jan; 25(1):43-54. PubMed ID: 17049676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
    Yang Y; Yin J; Guo D; Lang X; Wang X
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):159-67. PubMed ID: 21166726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.
    Abbassi-Daloii T; Yousefi S; Sekhavati MH; Tahmoorespur M
    APMIS; 2018 Jan; 126(1):65-75. PubMed ID: 29154438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4
    Sahu R; Dixit S; Verma R; Duncan SA; Coats MT; Giambartolomei GH; Singh SR; Dennis VA
    Nanomedicine; 2020 Oct; 29():102257. PubMed ID: 32610072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections.
    Abkar M; Fasihi-Ramandi M; Kooshki H; Lotfi AS
    Immunol Lett; 2018 Jul; 199():53-60. PubMed ID: 29548705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization of mice with Omp31-loaded
    Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A
    Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
    Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
    Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
    Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
    Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to the CP24 protein of Brucella melitensis lack diagnostic usefulness in ovine brucellosis.
    Delpino MV; Cassataro J; Fossati CA; Baldi PC
    Vet Microbiol; 2003 May; 93(2):101-7. PubMed ID: 12636998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2017 Feb; 111():33-43. PubMed ID: 27865932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Schaefers MM; Duan B; Mizrahi B; Lu R; Reznor G; Kohane DS; Priebe GP
    Vaccine; 2018 Nov; 36(46):6926-6932. PubMed ID: 30314911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.